Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche's Virtual Pipeline Event: Phase 2 LADDER results of the Port Delivery System (PDS) with Lucentis to be presented at the 2018 ASRS annual meeting Mittwoch, 11. Juli 2018 - 10:15

F. Hoffmann-La Roche Ltd F. Hoffmann-La Roche Ltd

Invitation to Roche's Virtual Pipeline Event: Phase 2 LADDER results of the Port Delivery System (PDS) with Lucentis to be presented at the 2018 ASRS annual meeting

129480.jpg


We are pleased to invite 
investors and analysts to participate in a live audio webcast and conference call on Thursday, 2 August 2018, featuring data from the Phase 2 LADDER study of the Port Delivery System (RPDS) with Lucentis to be presented at the American Society of Retina Specialists (ASRS) annual meeting (20-25 July 2018) in Vancouver, Canada.

We would like to invite all interested parties to dial in as outlined below:

16:00 - 17:00 CEST / 15:00 - 16:00 BST
10:00 am - 12:00 pm EDT / 7:00 am - 8:00 am PDT

Audio webcast and conference call will start with presentations followed by a Q&A session (live access to the speakers).

The
 live audio webcast can be accessed via ir.roche.com.


In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this 
link

If you have not pre-registered, please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.

+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

Presentation slides will be posted on the Roche IR website. 

A replay of the webcast will be available via 
ir.roche.com.


Best regards,


Karl Mahler                                                      Loren Kalm
Head of Investor Relations                              Investor Relations Officer

 

Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Susann Manchado
Phone: +41 61-68-75619
e-mail: 
susann.manchado@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com


 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com

 

 





All rights reserved ©2018 F. Hoffmann-La Roche Ltd.